Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis

被引:0
|
作者
Abrar Ahmad
Lee-Ling Lim
Mario Luca Morieri
Claudia Ha-ting Tam
Feifei Cheng
Tinashe Chikowore
Monika Dudenhöffer-Pfeifer
Hugo Fitipaldi
Chuiguo Huang
Sarah Kanbour
Sudipa Sarkar
Robert Wilhelm Koivula
Ayesha A. Motala
Sok Cin Tye
Gechang Yu
Yingchai Zhang
Michele Provenzano
Diana Sherifali
Russell J. de Souza
Deirdre Kay Tobias
Maria F. Gomez
Ronald C. W. Ma
Nestoras Mathioudakis
机构
[1] Lund University Diabetes Centre,Department of Clinical Sciences
[2] Lund University,Department of Medicine, Faculty of Medicine
[3] University of Malaya,Department of Medicine and Therapeutics
[4] The Chinese University of Hong Kong,Metabolic Disease Unit
[5] Asia Diabetes Foundation,Department of Medicine
[6] University Hospital of Padova,Laboratory for Molecular Epidemiology in Diabetes, Li Ka Shing Institute of Health Sciences
[7] University of Padova,Hong Kong Institute of Diabetes and Obesity
[8] The Chinese University of Hong Kong,Health Management Center
[9] The Chinese University of Hong Kong,MRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences
[10] The Second Affiliated Hospital of Chongqing Medical University,Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences
[11] Chongqing Medical University,Department of Medicine
[12] University of the Witwatersrand,Oxford Centre for Diabetes, Endocrinology and Metabolism
[13] University of the Witwatersrand,Department of Diabetes and Endocrinology, Nelson R Mandela School of Medicine
[14] AMAN Hospital,Department of Clinical Pharmacy and Pharmacology
[15] Johns Hopkins University School of Medicine,Sections on Genetics and Epidemiology
[16] University of Oxford,Nephrology, Dialysis and Renal Transplant Unit
[17] University of KwaZulu-Natal,Heather M. Arthur Population Health Research Institute
[18] University Medical Center Groningen,Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences
[19] Joslin Diabetes Center,Population Health Research Institute
[20] Harvard Medical School,Faculty of Health
[21] IRCCS—Azienda Ospedaliero-Universitaria di Bologna,Division of Preventative Medicine, Department of Medicine
[22] Alma Mater Studiorum University of Bologna,Department of Nutrition
[23] McMaster University,Novo Nordisk Foundation Center for Basic Metabolic Research
[24] McMaster University,Diabetes Unit, Endocrine Division
[25] Hamilton Health Sciences Corporation,Center for Genomic Medicine
[26] Harvard T.H. Chan School of Public Health,Department of Obstetrics and Gynaecology
[27] Aarhus University,NIHR Cambridge Biomedical Research Centre
[28] Brigham and Women’s Hospital and Harvard Medical School,Departments of Medicine and Community Health Sciences, Cumming School of Medicine
[29] Harvard T.H. Chan School of Public Health,Department of Molecular Genetics
[30] Faculty of Health and Medical Sciences,Division of Pediatric Endocrinology, Department of Pediatrics
[31] University of Copenhagen,Department of Clinical and Biomedical Sciences
[32] Massachusetts General Hospital,Departament de Medicina
[33] Massachusetts General Hospital,Department of Medicine
[34] the Rosie Hospital,Division of Endocrinology, Diabetes and Metabolism
[35] University of Cambridge,Department of Pediatrics
[36] University of Calgary,Herman B Wells Center for Pediatric Research
[37] Madras Diabetes Research Foundation,Center for Diabetes and Metabolic Diseases
[38] Saint Louis University School of Medicine,Department of Biostatistics and Epidemiology
[39] SSM Health Cardinal Glennon Children’s Hospital,Department of Nutrition
[40] University of Exeter Medical School,Research Center
[41] CIBER-BBN,Department of Pediatrics
[42] ISCIII,Division of Population Health & Genomics, School of Medicine
[43] Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU),Department of Pediatrics
[44] Universitat Autònoma de Barcelona,Stanford Diabetes Research Center
[45] Programs in Metabolism and Medical & Population Genetics,Department of Nutrition
[46] Broad Institute,Institute for Molecular Medicine Finland FIMM
[47] Harvard Medical School,Department of Pediatrics, Division of Endocrinology
[48] Johns Hopkins University School of Medicine,Department of Medicine & Therapeutics
[49] Indiana University School of Medicine,Departments of Pediatrics and Clinical Genetics
[50] Indiana University School of Medicine,Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
People living with type 2 diabetes (T2D) are more likely to develop problems with their heart or blood circulation, known as cardiovascular disease (CVD), than people who do not have T2D. However, it can be difficult to predict which people with T2D are most likely to develop CVD. This is because current approaches, such as blood tests, do not identify all people with T2D who are at an increased risk of CVD. In this study we reviewed published papers that investigated the differences between people with T2D who experienced CVD compared to those who did not. We found some indicators that could potentially be used to determine which people with T2D are most likely to develop CVD. More studies are needed to determine how useful these are. However, they could potentially be used to enable clinicians to provide targeted advice and treatment to those people with T2D at most risk of developing CVD.
引用
收藏
相关论文
共 50 条
  • [41] Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes
    Eleni Bekiari
    Chrysoula Rizava
    Eleni Athanasiadou
    Konstantinos Papatheodorou
    Aris Liakos
    Thomas Karagiannis
    Maria Mainou
    Maria Rika
    Panagiota Boura
    Apostolos Tsapas
    Endocrine, 2016, 52 : 458 - 480
  • [42] Relation of Whole Grain Intake to Risk of Type 2 Diabetes, Cardiovascular Disease and Weight Gain: A Systematic Review and Meta-Analysis
    Chacko, Sara
    Ye, Eva Qing
    Chou, Elizabeth L.
    Kugizaki, Matthew
    Liu, Simin
    FASEB JOURNAL, 2012, 26
  • [43] Opium use and type 2 diabetes: a systematic review and meta-analysis
    Piraiee, Elahe
    Hassanipour, Soheil
    Shojaie, Layla
    Vali, Mohebat
    Nikbakht, Hossein-Ali
    Rezaei, Fatemeh
    Ghaem, Haleh
    JOURNAL OF SUBSTANCE USE, 2022, 27 (05) : 452 - 458
  • [44] Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis
    Dong, Kai
    Wang, Shenghai
    Qu, Chunhui
    Zheng, Kewei
    Sun, Ping
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [45] Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis
    Andreadis, Panagiotis
    Karagiannis, Thomas
    Malandris, Konstantinos
    Avgerinos, Ioannis
    Liakos, Aris
    Manolopoulos, Apostolos
    Bekiari, Eleni
    Matthews, David R.
    Tsapas, Apostolos
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2255 - 2263
  • [46] Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes
    Bekiari, Eleni
    Rizava, Chrysoula
    Athanasiadou, Eleni
    Papatheodorou, Konstantinos
    Liakos, Aris
    Karagiannis, Thomas
    Mainou, Maria
    Rika, Maria
    Boura, Panagiota
    Tsapas, Apostolos
    ENDOCRINE, 2016, 52 (03) : 458 - 480
  • [47] Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis
    Avgerinos, Ioannis
    Michailidis, Theodoros
    Liakos, Aris
    Karagiannis, Thomas
    Matthews, David R.
    Tsapas, Apostolos
    Bekiari, Eleni
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 335 - 345
  • [48] Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
    Pelluri, R.
    Kongara, S.
    Nagasubramanian, V. R.
    Mahadevan, S.
    Chimakurthy, J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (05) : 855 - 867
  • [49] Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis
    Delpino, Felipe Mendes
    Figueiredo, Lilian Munhoz
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2022, 62 (16) : 4465 - 4480
  • [50] Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis
    Avgerinos, Ioannis
    Karagiannis, Thomas
    Kakotrichi, Panagiota
    Michailidis, Theodoros
    Liakos, Aris
    Matthews, David R.
    Tsapas, Apostolos
    Bekiari, Eleni
    DIABETES OBESITY & METABOLISM, 2022, 24 (01): : 106 - 114